Shares of Eurofins Scient (OTCMKTS:ERFSF – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $76.35, but opened at $82.22. Eurofins Scient shares last traded at $82.22, with a volume of 6 shares.
Analyst Ratings Changes
ERFSF has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Eurofins Scient in a research report on Wednesday, October 29th. Citigroup reaffirmed a “neutral” rating on shares of Eurofins Scient in a research note on Monday, February 2nd. Finally, BNP Paribas Exane raised shares of Eurofins Scient to an “outperform” rating in a research report on Monday, January 5th. One research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.
Get Our Latest Stock Report on Eurofins Scient
Eurofins Scient Trading Up 4.1%
Eurofins Scient Company Profile
Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.
Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.
Further Reading
- Five stocks we like better than Eurofins Scient
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- REVEALED: Something Big Happening Behind White House Doors
- Gilder: Don’t Buy AI Stocks, Do This Instead
- Read this or regret it forever
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
